Keiji Iida Selected Research

Keiji Iida Research Topics

Disease

4	Muscular Atrophy (Muscle Atrophy) 09/2012 - 12/2004
4	Hypothyroidism 01/2011 - 06/2003
4	Obesity 12/2007 - 12/2005
3	COVID-19 01/2023 - 06/2022
3	Hypopituitarism (Sheehan's Syndrome) 11/2022 - 12/2004
3	Hypoglycemia (Reactive Hypoglycemia) 12/2018 - 01/2009
3	Insulin Resistance 06/2010 - 03/2007
3	Body Weight (Weight, Body) 04/2008 - 12/2005
3	Heart Failure 07/2006 - 09/2002
2	Neoplasms (Cancer) 01/2024 - 03/2004
2	Infections 06/2022 - 07/2002
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2018 - 09/2015
2	Osteoporosis 01/2011 - 04/2008
2	Acromegaly 06/2010 - 01/2008
2	Hepatocellular Carcinoma (Hepatoma) 12/2007 - 02/2002
2	Hyperlipidemias (Hyperlipidemia) 04/2007 - 12/2002
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 04/2024
1	Vasculitis (Vasculitides) 04/2024
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024
1	Thymoma (Thymic Carcinoma) 01/2024
1	Hypophysitis 12/2023
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 11/2022
1	Hypogonadism (Hypergonadotropic Hypogonadism) 11/2022
1	Hypotension (Low Blood Pressure) 11/2022
1	Subacute Sclerosing Panencephalitis (SSPE) 09/2022
1	Measles 09/2022
1	Hyponatremia 06/2014
1	Thyroiditis 01/2011
1	Myxedema 01/2011
1	Coma (Comas) 01/2011
1	Muscular Diseases (Myopathy) 06/2010
1	Atrophy 06/2010
1	Insulinoma 01/2010
1	Pituitary Dwarfism 01/2009
1	Combined Pituitary Hormone Deficiency 11/2008
1	Laron Syndrome (Syndrome, Laron) 04/2008
1	Inborn Genetic Diseases (Disease, Hereditary) 04/2008
1	Inflammation (Inflammations) 12/2007
1	Hypoadiponectinemia 06/2007

Drug/Important Bio-Agent (IBA)

8	Growth Hormone (Somatotropin)IBA 01/2024 - 03/2004
8	Insulin (Novolin)FDA Link 11/2022 - 02/2002
7	Glucose (Dextrose)FDA LinkGeneric 12/2018 - 05/2005
4	ProlactinIBA 01/2024 - 06/2003
4	Proteins (Proteins, Gene)FDA Link 09/2012 - 12/2002
4	Insulin-Like Growth Factor I (IGF-1)IBA 06/2010 - 01/2008
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2024 - 01/2011
3	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2022 - 04/2007
3	Immunoglobulin G (IgG)IBA 09/2022 - 07/2002
3	Hormones (Hormone)IBA 06/2022 - 04/2007
3	UbiquitinIBA 09/2012 - 03/2004
3	Messenger RNA (mRNA)IBA 01/2009 - 12/2004
2	Transcription Factors (Transcription Factor)IBA 12/2023 - 03/2004
2	EnzymesIBA 01/2023 - 09/2022
2	ChemokinesIBA 01/2023 - 12/2007
2	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2022 - 12/2004
2	insulin degludecIBA 12/2018 - 09/2015
2	Insulin Glargine (Lantus)FDA Link 12/2018 - 09/2015
2	C-PeptideIBA 12/2018 - 09/2015
2	Branched-Chain Amino AcidsIBA 09/2012 - 06/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2010 - 03/2007
2	Ligases (Synthetase)IBA 02/2008 - 03/2004
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2006 - 05/2006
2	GhrelinIBA 12/2005 - 02/2002
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2024
1	Antithyroid Agents (Antithyroid Drugs)IBA 04/2024
1	Propylthiouracil FDA Link 04/2024
1	Immune Checkpoint InhibitorsIBA 12/2023
1	Interleukin-18 (Interleukin 18)IBA 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	ImmunosorbentsIBA 01/2023
1	InterleukinsIBA 01/2023
1	Chemokine CXCL9IBA 01/2023
1	LigandsIBA 01/2023
1	CytokinesIBA 01/2023
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	Testosterone (Sustanon)FDA Link 11/2022
1	Thyroid HormonesIBA 06/2022
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 06/2022
1	InsulinsIBA 12/2018
1	MineralocorticoidsIBA 06/2014
1	Indicators and Reagents (Reagents)IBA 09/2012
1	Proteasome Endopeptidase Complex (Proteasome)IBA 09/2012
1	Carcinoembryonic AntigenIBA 01/2011
1	Iodide Peroxidase (Deiodinase)IBA 01/2011
1	anti-thyroglobulinIBA 01/2011
1	Cysteine (L-Cysteine)FDA Link 06/2010
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2010
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 06/2010
1	SteroidsIBA 06/2010
1	AntioxidantsIBA 06/2010
1	PPAR deltaIBA 01/2009
1	OsteocalcinIBA 04/2008
1	deoxypyridinolineIBA 04/2008
1	Somatotropin Receptors (Growth Hormone Receptor)IBA 04/2008
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 04/2008
1	growth hormone-releasing peptide-2 (KP 102)IBA 02/2008

Therapy/Procedure

4	Therapeutics 04/2024 - 09/2002
2	Injections 12/2018 - 09/2015
1	Critical Care (Surgical Intensive Care) 11/2022
1	Glycemic Control 12/2018